MEDICAL DIAGNOSTIC TESTS COMPRISED PRIMARILY

Brand	Owner	Address	Description
FIRSTCARE	PRINCETON BIOMEDITECH CORPORATION	4242 U.S. Highway 1 MONMOUTH JUNCTION NJ 08852	MEDICAL DIAGNOSTIC TESTS COMPRISED PRIMARILY OF CARDIAC MARKERS AND DIAGNOSTIC REAGENTS FOR USE IN CONNECTION WITH RAPID IMMUNOASSAY TESTING IN THE FIELDS OF ABUSED DRUGS, CANCER DIAGNOSIS, CARDIAC DISORDERS, CHEMICAL DISORDERS, COAGULATION, ENDOCRINOLOGICAL DISORDERS, FERTILITY, INFECTIOUS DISEASE, HEMATOLOGY, IMMUNOLOGICAL DISORDERS, AND PHYSIOLOGICAL AND NEUROLOGICAL DISORDERS;1ST CARE;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Appropriate determinations in a series of tests, which transition from more passive tests to more active tests, control the admission of data streams onto a network data path. More passive tests can include promiscuous mode and packet-pair tests. When the results of more passive tests indicate a reduce likelihood of a data stream causing a network data path to transition into a congested state, the network data path can be actively probed to make a more precise determination on the likelihood of congestion. A train of diagnostic data packets is transmitted at a diagnostic data transfer rate having a significantly reduced chance of causing congestion. A train of target data packets is transmitted at a requested application transfer data rate. The number of target data packets received within a specified delay threshold is compared to the number of diagnostic data packets receive with the delay threshold.